Host-directed therapeutics for tuberculosis: can we harness the host?
TR Hawn, AI Matheson, SN Maley… - … and Molecular Biology …, 2013 - Am Soc Microbiol
Treatment of tuberculosis (TB) remains challenging, with lengthy treatment durations and
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
[HTML][HTML] Host-directed therapeutics for tuberculosis: can we harness the host?
TR Hawn, AI Matheson, SN Maley… - … and Molecular Biology …, 2013 - europepmc.org
Treatment of tuberculosis (TB) remains challenging, with lengthy treatment durations and
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
Host-directed therapeutics for tuberculosis: can we harness the host?
TR Hawn, AI Matheson, SN Maley… - … and Molecular Biology …, 2013 - hero.epa.gov
Abstract Treatment of tuberculosis (TB) remains challenging, with lengthy treatment
durations and complex drug regimens that are toxic and difficult to administer. Similar to the …
durations and complex drug regimens that are toxic and difficult to administer. Similar to the …
[PDF][PDF] Host-Directed Therapeutics for Tuberculosis: Can We Harness the Host?
TR Hawn, AI Matheson, SN Maley, O Vandalc - 2013 - researchgate.net
Treatment of tuberculosis (TB) remains challenging, with lengthy treatment durations and
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
[PDF][PDF] Host-Directed Therapeutics for Tuberculosis: Can We Harness the Host?
TR Hawn, AI Matheson, SN Maley, O Vandalc - 2013 - Citeseer
Treatment of tuberculosis (TB) remains challenging, with lengthy treatment durations and
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
[HTML][HTML] Host-Directed Therapeutics for Tuberculosis: Can We Harness the Host?
TR Hawn, AI Matheson, SN Maley… - … and Molecular Biology …, 2013 - ncbi.nlm.nih.gov
Treatment of tuberculosis (TB) remains challenging, with lengthy treatment durations and
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
Host-directed therapeutics for tuberculosis: can we harness the host?
TR Hawn, AI Matheson, SN Maley… - Microbiology and …, 2013 - pubmed.ncbi.nlm.nih.gov
Treatment of tuberculosis (TB) remains challenging, with lengthy treatment durations and
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
[PDF][PDF] Host-Directed Therapeutics for Tuberculosis: Can We Harness the Host?
TR Hawn, AI Matheson, SN Maley, O Vandalc - 2013 - uwstartcenter.org
Treatment of tuberculosis (TB) remains challenging, with lengthy treatment durations and
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
Host-directed therapeutics for tuberculosis: can we harness the host?
TR Hawn, AI Matheson, SN Maley… - … and Molecular Biology …, 2013 - europepmc.org
Treatment of tuberculosis (TB) remains challenging, with lengthy treatment durations and
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …
complex drug regimens that are toxic and difficult to administer. Similar to the vast majority of …